BARICITINIB: NEW PHARMACOTHERAPY OPTIONS FOR RHEUMATOID ARTHRITIS AND OTHER IMMUNE-MEDIATED INFLAMMATORY RHEUMATIC DISEASES
Deciphering the mechanisms of the pathogenesis of immune-mediated inflammatory rheumatic diseases (IMIRDs) in conjunction with designing a wide range of biological agents is one of the major medical advances in the 21st century. A new promising area of pharmacotherapy for IMIRDs is associated with t...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
IMA PRESS LLC
2020-06-01
|
| Col·lecció: | Научно-практическая ревматология |
| Matèries: | |
| Accés en línia: | https://rsp.mediar-press.net/rsp/article/view/2898 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|